Find similar content

Source channel @githubtrending · Post #14847 · Jun 20

#java#bedrock#bedrock_edition#bedrock_to_java#bungee#fabric#geyser#geysermc#hacktoberfest#java#java_edition#minecraft#minecraft_bedrock_edition#packet#pe#protocol#proxy#spigot#translator#velocity Geyser is a free tool that lets you play Minecraft across different versions by connecting Minecraft Java Edition servers. It works by translating data between the two game versions, enabling cross-platform play on devices like Windows, iOS, Android, and consoles. You can install it as a plugin or standalone, and it supports recent Minecraft versions. This means you can join Java servers even if you only have Bedrock Edition, expanding your multiplayer options without needing a separate Java account if you use the Floodgate plugin. It’s great for seamless crossplay but may have some minor limitations due to game differences[1][2][5]. https://github.com/GeyserMC/Geyser

Hashtags

#java #bedrock #bedrock_edition #bedrock_to_java #bungee #fabric #geyser #geysermc #hacktoberfest #java_edition #minecraft #minecraft_bedrock_edition #packet #pe #protocol #proxy #spigot #translator #velocity

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment